These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16501211)

  • 1. The left ventricle in aortic stenosis: evidence for the use of ACE inhibitors.
    Chambers J
    Heart; 2006 Mar; 92(3):420-3. PubMed ID: 16501211
    [No Abstract]   [Full Text] [Related]  

  • 2. ACE inhibition in aortic stenosis: dangerous medicine or golden opportunity?
    Routledge HC; Townend JN
    J Hum Hypertens; 2001 Oct; 15(10):659-67. PubMed ID: 11607794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis?
    Shavelle DM
    Heart; 2005 Oct; 91(10):1257-9. PubMed ID: 16162605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibition in aortic stenosis: an intriguing hypothesis, not a proven therapy.
    Otto CM
    J Hum Hypertens; 2001 Oct; 15(10):655-7. PubMed ID: 11607793
    [No Abstract]   [Full Text] [Related]  

  • 5. Aortic stenosis and angiotensin-converting enzyme inhibitors--rupture of an ancient paradigm?
    Barrera-Ramírez CF; Pineda-Pompa LR; Ilarraza H
    Am Heart J; 2005 Feb; 149(2):E5; author reply E7. PubMed ID: 15846247
    [No Abstract]   [Full Text] [Related]  

  • 6. [Angiotensin-converting-enzyme inhibitor and heart hypertrophy].
    Riegger AJ; Kromer EP
    Wien Med Wochenschr; 1990 Jan; 140(1-2):46-9. PubMed ID: 2137956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why deny ACE inhibitors to patients with aortic stenosis?
    Cox NL; Abdul-Hamid AR; Mulley GP
    Lancet; 1998 Jul; 352(9122):111-2. PubMed ID: 9672278
    [No Abstract]   [Full Text] [Related]  

  • 8. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter regarding article by Rosenhek et al, "statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis".
    Routledge HC; Townend JN
    Circulation; 2005 May; 111(17):e274-5; author reply e274-5. PubMed ID: 15867188
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: a drug withdrawal study.
    Jiménez-Candil J; Bermejo J; Yotti R; Cortina C; Moreno M; Cantalapiedra JL; García-Fernández MA
    Heart; 2005 Oct; 91(10):1311-8. PubMed ID: 16162624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibitors in aortic stenosis: no fear just hope.
    Davin L; Dulgheru R; Lancellotti P
    Eur Heart J Cardiovasc Imaging; 2015 Aug; 16(8):828-30. PubMed ID: 25896359
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neurohormonal profile in aortic valve stenosis].
    Ramirez-Gil JF; Drobinski G; Carayon A; Isnard R; Hoffman O; Sotirov I; Chanton E; Montalescot G; Thomas D
    Arch Mal Coeur Vaiss; 1993 Jul; 86(7):1001-7. PubMed ID: 8291934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors and effects on left ventricular hypertrophy.
    Dahlöf B
    Blood Press Suppl; 1994; 2():35-40. PubMed ID: 8061844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
    Schön HR
    J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).
    Chockalingam A; Venkatesan S; Subramaniam T; Jagannathan V; Elangovan S; Alagesan R; Gnanavelu G; Dorairajan S; Krishna BP; Chockalingam V;
    Am Heart J; 2004 Apr; 147(4):E19. PubMed ID: 15077102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of myocardial estrogen receptors in human aortic stenosis.
    Nordmeyer J; Eder S; Mahmoodzadeh S; Martus P; Fielitz J; Bass J; Bethke N; Zurbrügg HR; Pregla R; Hetzer R; Regitz-Zagrosek V
    Circulation; 2004 Nov; 110(20):3270-5. PubMed ID: 15533858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis and Aortic Stenosis: 'Killing Two Birds with One Stone'?
    Lazaros G; Benetos G; Toutouzas K; Tousoulis D
    Cardiology; 2015; 132(1):9-10. PubMed ID: 25997816
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of post-infarction left ventricular remodeling by ACE-inhibitors.
    St John Sutton M; Pfeffer MA
    Cardiologia; 1994 Dec; 39(12 Suppl 1):27-30. PubMed ID: 7634281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves.
    Côté N; Couture C; Pibarot P; Després JP; Mathieu P
    Eur J Clin Invest; 2011 Nov; 41(11):1172-9. PubMed ID: 21988540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respective impacts of aortic stenosis and systemic hypertension on left ventricular hypertrophy.
    Garcia D; Pibarot P; Kadem L; Durand LG
    J Biomech; 2007; 40(5):972-80. PubMed ID: 16750211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.